- Home
- STG vs SER Comparison
STG vs SER Comparison
Compare STG & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- SER
- Stock Information
- Founded
- STG 2003
- SER 2017
- Country
- STG China
- SER United States
- Employees
- STG N/A
- SER N/A
- Industry
- STG Other Consumer Services
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- SER Health Care
- Exchange
- STG Nasdaq
- SER Nasdaq
- Market Cap
- STG 70.3M
- SER 56.5M
- IPO Year
- STG 2018
- SER 2018
- Fundamental
- Price
- STG $5.72
- SER $5.90
- Analyst Decision
- STG
- SER Strong Buy
- Analyst Count
- STG 0
- SER 1
- Target Price
- STG N/A
- SER $11.00
- AVG Volume (30 Days)
- STG 3.0K
- SER 10.4K
- Earning Date
- STG 05-22-2025
- SER 05-08-2025
- Dividend Yield
- STG N/A
- SER N/A
- EPS Growth
- STG N/A
- SER N/A
- EPS
- STG 3.09
- SER N/A
- Revenue
- STG $269,356,990.00
- SER $51,000.00
- Revenue This Year
- STG N/A
- SER N/A
- Revenue Next Year
- STG N/A
- SER N/A
- P/E Ratio
- STG $1.81
- SER N/A
- Revenue Growth
- STG N/A
- SER N/A
- 52 Week Low
- STG $4.25
- SER $3.81
- 52 Week High
- STG $11.06
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- STG 59.74
- SER 54.82
- Support Level
- STG $5.31
- SER $5.01
- Resistance Level
- STG $5.56
- SER $6.00
- Average True Range (ATR)
- STG 0.22
- SER 0.32
- MACD
- STG 0.05
- SER 0.01
- Stochastic Oscillator
- STG 92.45
- SER 81.65
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.